Horan Securities’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-65
Closed 542
2021
Q4
$0 Buy
+65
New +$280 ﹤0.01% 534
2021
Q2
$0 Hold
65
﹤0.01% 484
2021
Q1
$0 Hold
65
﹤0.01% 444
2020
Q4
$1K Hold
65
﹤0.01% 386
2020
Q3
$0 Hold
65
﹤0.01% 377
2020
Q2
$0 Hold
65
﹤0.01% 358
2020
Q1
$0 Buy
+65
New +$280 ﹤0.01% 279
2019
Q4
Sell
-65
Closed 174
2019
Q3
$0 Hold
65
﹤0.01% 276
2019
Q2
$0 Hold
65
﹤0.01% 296
2019
Q1
$0 Buy
+65
New +$451 ﹤0.01% 236

Other funds holding PGEN

Horan Securities's PGEN Position: Q1 2022 in Review

Horan Securities sold out of Precigen (PGEN) in Q1 2022, closing a stake of 65 shares.

Horan Securities first reported a position in PGEN in Q1 2019 and held it in 10 quarters. The position peaked at $1K in Q4 2020. 173 funds tracked by Wall St. Rank hold PGEN as of Q1 2022.

  • Horan Securities reported no remaining Precigen position as of Q1 2022 after selling out during the quarter.
  • Horan Securities sold 65 Precigen shares in Q1 2022.
  • Horan Securities first reported a position in Precigen in Q1 2019 and held it in 10 quarters.
  • Horan Securities's Precigen position peaked at $1K in Q4 2020.
  • 173 funds tracked by Wall St. Rank held Precigen as of Q1 2022.

Based on Horan Securities's 13F filing for Q1 2022, filed 10 May 2022.